ARKG
ThematicARK Genomic Revolution ETF
-$140M
Week flow (estimated)
AUM
$1.20B
Expense Ratio
0.75%
Dividend Yield
+0.00%
YTD Return
-32.10%
Key Stats
Month Flow-$480M
AUM$1.20B
Expense Ratio0.75%
Dividend Yield0.00%
YTD Return-32.10%
Advertisement
About ARKG
Focuses on companies involved in genomics, CRISPR, and biotech innovation.
Frequently Asked Questions
What is ARKG ETF?
Focuses on companies involved in genomics, CRISPR, and biotech innovation.
How much has ARKG gained this year?
ARKG has returned -32.10% year-to-date (estimated). Past performance does not guarantee future results.
What is ARKG's expense ratio?
ARKG has an expense ratio of 0.75%. For every $10,000 invested, you pay approximately $75.00 per year in management fees.